Related Experiment Videos
Occurrence of monoclonal components in general practice: clinical implications
F Aguzzi1, M R Bergami, C Gasparro
1Central Laboratory, Hospital of Stradella, Pavia, Italy.
European Journal of Haematology
|April 1, 1992
Summary
Monoclonal components (MC) increase with age, plateauing after 55. Most detected MC are low concentration, suggesting current concepts on their significance need revision.
Area of Science:
- Clinical Chemistry
- Immunology
- Hematology
Background:
- Monoclonal components (MC) are abnormal proteins often detected incidentally.
- Previous studies focused on high-concentration MC, potentially overlooking low-concentration cases.
Purpose of the Study:
- To investigate the prevalence and characteristics of monoclonal components in a defined population.
- To assess the clinical significance of incidentally discovered low-concentration MC.
Main Methods:
- Serum electrophoresis for initial detection of monoclonal components.
- Immunofixation for precise typing of detected monoclonal components.
- Analysis of prevalence based on age and concentration.
Main Results:
- Monoclonal component prevalence increases significantly with age, reaching 7-8% in individuals over 55.
- Approximately 80% of identified monoclonal components were low concentration (<5 g/l).
- Many low-concentration MC cases were likely missed in prior prognostic studies.
Conclusions:
- Age is a major factor in monoclonal component occurrence.
- A substantial proportion of monoclonal components are low concentration and may have different clinical implications.
- Current understanding of the biological and clinical significance of incidentally found monoclonal components requires re-evaluation.